China National Medicines Corporation Ltd. (SHA:600511)

SHA:600511 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10,886	10,926	8,896	7,304	6,225
Trading Asset Securities	-	-	-	11.4	-
Cash & Short-Term Investments	10,886	10,926	8,896	7,316	6,225
Cash Growth	-0.36%	22.81%	21.60%	17.53%	9.16%
Accounts Receivable	13,931	12,881	12,550	13,392	12,507
Other Receivables	363.11	204	389.69	79.93	129.77
Receivables	14,294	13,085	12,940	13,472	12,637
Inventory	4,956	3,961	3,717	3,515	3,050
Other Current Assets	221.63	307.79	210.44	280.62	198.65
Total Current Assets	30,357	28,279	25,764	24,584	22,110
Property, Plant & Equipment	878.6	827.04	857.91	845.06	895.73
Long-Term Investments	2,176	1,907	1,623	1,365	1,141
Goodwill	203.77	203.77	203.77	203.77	203.77
Other Intangible Assets	276.76	258.11	262.92	258.65	256.12
Long-Term Deferred Tax Assets	149.07	123.87	124.37	115.94	100.6
Long-Term Deferred Charges	152.39	150.06	86.19	89.6	90.31
Other Long-Term Assets	734.85	703.57	686.95	548.08	108.13
Total Assets	34,928	32,453	29,609	28,010	24,905
Accounts Payable	12,086	10,943	9,917	10,058	8,990
Accrued Expenses	169.56	604.96	640.01	564.03	514.43
Short-Term Debt	485.06	268.35	252.06	428.83	471.83
Current Portion of Long-Term Debt	100.2	-	-	-	-
Current Portion of Leases	-	74.08	80.5	75.81	70.12
Current Income Taxes Payable	236.52	113.17	84.89	112.18	76.99
Current Unearned Revenue	275.25	61.12	176.9	43.68	66.59
Other Current Liabilities	1,503	1,830	1,589	1,457	1,047
Total Current Liabilities	14,856	13,894	12,740	12,739	11,237
Long-Term Leases	260.69	205.08	182.57	197.29	260.09
Long-Term Unearned Revenue	38.79	46.06	46.35	42.66	45.53
Long-Term Deferred Tax Liabilities	24.19	26.78	33.47	35.39	40.84
Other Long-Term Liabilities	773.82	747.14	747.14	639.8	226.62
Total Liabilities	15,953	14,920	13,750	13,655	11,811
Common Stock	754.5	754.5	754.5	754.5	754.5
Additional Paid-In Capital	2,349	2,349	2,349	2,349	2,349
Retained Earnings	13,997	12,642	11,087	9,652	8,312
Comprehensive Income & Other	27.28	30.74	24.04	24.91	27.69
Total Common Equity	17,128	15,776	14,215	12,780	11,444
Minority Interest	1,847	1,757	1,645	1,575	1,650
Shareholders' Equity	18,975	17,533	15,859	14,355	13,094
Total Liabilities & Equity	34,928	32,453	29,609	28,010	24,905
Total Debt	845.95	547.5	515.13	701.93	802.04
Net Cash (Debt)	10,040	10,378	8,381	6,614	5,423
Net Cash Growth	-3.26%	23.83%	26.72%	21.97%	5.41%
Net Cash Per Share	13.31	13.76	11.11	8.77	7.19
Filing Date Shares Outstanding	754.48	754.5	754.5	754.5	754.5
Total Common Shares Outstanding	754.48	754.5	754.5	754.5	754.5
Working Capital	15,501	14,385	13,025	11,845	10,872
Book Value Per Share	22.70	20.91	18.84	16.94	15.17
Tangible Book Value	16,648	15,314	13,748	12,318	10,984
Tangible Book Value Per Share	22.07	20.30	18.22	16.33	14.56
Buildings	-	408.84	433.49	387.18	381.37
Machinery	-	759.8	702.78	661.15	629.64
Construction In Progress	-	2.54	36.21	57.09	13.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.